VERRARI - "Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"

NCT00180427 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2008-04-24

No results posted yet for this study

Summary

"The purpose of this study is to evaluate the influence of the rate response function of implantable cardioverter defibrillators (ICDs) on the frequency of ventricular arrhythmias in patients with an ICD."

Conditions

  • Ventricular Fibrillation

Interventions

DEVICE

ICD

Sponsors & Collaborators

  • Guidant Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Niehaus, MD · Hannover Medical School

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Completion
2004-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180427 on ClinicalTrials.gov